Evidence map›Paper›PMID 28959706›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2017

Loss of corticospinal tract integrity in early MS disease stages.

Marc Pawlitzki, Jens Neumann, Jörn Kaufmann, Jan Heidel, Erhard Stadler, Catherine Sweeney-Reed, Michael Sailer, Stefanie Schreiber

Abstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marc PawlitzkiDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Jens NeumannDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Jörn KaufmannDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Jan HeidelDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Erhard StadlerDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Catherine Sweeney-ReedDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Michael SailerDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.
Stefanie SchreiberDepartment of Neurology (M.P., J.N., J.K., J.H., E.S., C.S.-R., S.S.), Otto von Guericke University; MEDIAN Klinik NRZ Magdeburg (M.S.), Affiliated Institute for Neurorehabilitation of the Otto von Guericke University; and German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association (S.S.), Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe investigated corticospinal tract (CST) integrity in the absence of white matter (WM) lesions using diffusion tensor imaging (DTI) in early MS disease stages.

methodsOur study comprised 19 patients with clinically isolated syndrome (CIS), 11 patients with relapsing-remitting MS (RRMS), and 32 age- and sex-matched healthy controls, for whom MRI measures of CST integrity (fractional anisotropy [FA], mean diffusivity [MD]), T1- and T2-based lesion load, and brain volumes were available. The mean (SD) disease duration was 3.5 (2.1) months, and disability score was low (median Expanded Disability Status Scale 1.5) at the time of the study.

resultsPatients with CIS and RRMS had significantly lower CST FA and higher CST MD values compared with controls. These findings were present, irrespective of whether WM lesions affected the CST. However, no group differences in the overall gray or WM volume were identified.

conclusionsIn early MS disease stages, CST integrity is already affected in the absence of WM lesions or brain atrophy.

Identifiers

PMID28959706
PMCPMC5614727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.